Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Neuroblastoma × Doxorubicin × Clear all

Phase

Phase 2 15 Phase 3 11 Phase 1 6 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Lymphoma 9 Sarcoma 6 Nausea 5 Vomiting 4 Lymphoma, Non-Hodgkin 4 Carcinoma, Hepatocellular 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Large B-Cell, Diffuse 3 Recurrence 2 Osteosarcoma 2 Neoplasm Metastasis 2 Lymphoma, Large-Cell, Anaplastic 2 Leukemia 2 Breast Neoplasms, Male 2 Triple Negative Breast Neoplasms 1 Somatostatinoma 1 Sezary Syndrome 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Motor Activity 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1

Interventions

Therapeutics 3 Isotretinoin 3 Etoposide 3 Cyclophosphamide 3 Vincristine 2 Stem Cell Transplantation 2 Radiotherapy, Image-Guided 2 Radiotherapy 2 Psychiatric Rehabilitation 2 Melphalan 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Granulocyte Colony-Stimulating Factor 2 Dexamethasone 2 Cisplatin 2 Carboplatin 2 Calcium Dobesilate 2 Aprepitant 2 sargramostim 1 pegfilgrastim 1 humanized 3F8 anti-GD2 monoclonal antibody 1 hetrombopag 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 Traumeel S 1 Topotecan 1 Sugars 1 Spermine Synthase 1 Ropivacaine 1 Radiation 1 Polymerase Chain Reaction 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02786719 2020-03-12

SPRING

Baylor College of Medicine

Phase NA Completed

13 enrolled 13 charts

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡